Core Laboratories Share Price (NYSE: CLB)

$11.33

▲

0.19

(1.71%)

Last updated on August 29, 2025 at 1:29 am IST

$₹

Check the interactive Core Laboratories Stock chart to analyse performance

Core Laboratories stock performance

as on August 29, 2025 at 1:29 am IST

Today's Low:$11.00
Today's High:$11.33
$11.33
2.91%
Downside
Day's Volatility :2.91%
Upside
0.0%
52 Weeks Low:$9.72
52 Weeks High:$21.83
$11.33
14.21%
Downside
52 Weeks Volatility :55.47%
Upside
48.1%

Core Laboratories Stock Returns

Period	Core Laboratories Inc	Sector (Energy)	Index (Russel 2000)
3 Months	3.63%	9.3%	0.0%
6 Months	-23.86%	-2.0%	0.0%
1 Year	-43.28%	-0.6%	0.0%
3 Years	-31.7%	7.7%	-6.9%

Core Laboratories Inc Key Stats

Check Core Laboratories key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$11.14
Open	$11.12
Today's High	$11.33
Today's Low	$11.0
Market Capitalization	$521.5M
Today's Volume	$449.2K
52 Week High	$21.83
52 Week Low	$9.72
Revenue TTM	$517.4M
EBITDA	$62.7M
Earnings Per Share (EPS)	$0.62
PE Ratio	17.94
Dividend Yield	0.36%
Profit Margin	5.73%
Quarterly Earnings Growth YOY	0.16%
Return On Equity TTM	11.78%

Stock Returns calculator for Core Laboratories Stock including INR - Dollar returns

The Core Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Core Laboratories investment value today

Current value as on today

₹64,156

Returns

₹35,844

(-35.84%)

Returns from Core Laboratories Stock

₹40,274 (-40.27%)

Dollar Returns*

₹4,430 (+4.43%)

Indian investors sentiment towards Core Laboratories Stock

-83%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Core Laboratories Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Core Laboratories Inc

Name
Holdings %
Name
Holdings %
Ariel Investments, LLC
27.67%
BlackRock Inc
16.01%
Disciplined Growth Investors Inc
11.60%
Vanguard Group Inc
9.55%
Earnest Partners LLC
7.68%
State Street Corp
4.12%

Analyst Recommendation on Core Laboratories Stock

Rating

Trend

Hold

0%Buy

53%Hold

46%Sell

Based on 15 Wall street analysts offering stock ratings for Core Laboratories(by analysts ranked 0 to 5 stars)

Core Laboratories Share Price Target

What analysts predicted

Upside of 32.39%

Target:

$15.00

Current:

$11.33

Core Laboratories share price target is $15.00, a slight Upside of 32.39% compared to current price of $11.33 as per analysts' prediction.

Core Laboratories Stock Insights

Price Movement
In the last 7 days, CLB stock has moved up by 6.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 123.58M → 130.15M (in $), with an average increase of 5.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -154.0K → 10.63M (in $), with an average increase of 101.5% per quarter
CLB vs FTI (1 yr)
In the last 1 year, Technipfmc Plc has given 36.6% return, outperforming this stock by 77.9%
CLB vs FTI (3 yr)
In the last 3 years, Technipfmc Plc has given 326.1% return, outperforming this stock by 360.0%
Price to Sales
ForCLB every $1 of sales, investors are willing to pay $1.0, whereas for Technipfmc Plc, the investors are paying $1.6 for every $1 of sales.

Core Laboratories Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$668.2M	↓ 4.66%
Net Income	$102.0M	↑ 28.24%
Net Profit Margin	15.26%	↑ 3.91%

	FY20	Y/Y Change
Revenue	$487.3M	↓ 27.08%
Net Income	$-97.2M	↓ 195.32%
Net Profit Margin	-19.95%	↓ 35.21%

	FY21	Y/Y Change
Revenue	$470.3M	↓ 3.49%
Net Income	$19.7M	↓ 120.29%
Net Profit Margin	4.19%	↑ 24.14%

	FY22	Y/Y Change
Revenue	$489.7M	↑ 4.14%
Net Income	$19.5M	↓ 1.39%
Net Profit Margin	3.97%	↓ 0.22%

	FY23	Y/Y Change
Revenue	$509.8M	↑ 4.1%
Net Income	$36.7M	↑ 88.53%
Net Profit Margin	7.19%	↑ 3.22%

	FY24	Y/Y Change
Revenue	$523.8M	↑ 2.76%
Net Income	$31.4M	↓ 14.38%
Net Profit Margin	5.99%	↓ 1.2%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$129.6M	↑ 1.11%
Net Income	$3.2M	↑ 46.43%
Net Profit Margin	2.48%	↑ 0.76%

	Q2 FY24	Q/Q Change
Revenue	$130.6M	↑ 0.73%
Net Income	$9.0M	↑ 180.5%
Net Profit Margin	6.92%	↑ 4.44%

	Q3 FY24	Q/Q Change
Revenue	$134.4M	↑ 2.93%
Net Income	$11.7M	↑ 30.04%
Net Profit Margin	8.74%	↑ 1.82%

	Q4 FY24	Q/Q Change
Revenue	$129.2M	↓ 3.84%
Net Income	$7.4M	↓ 36.97%
Net Profit Margin	5.73%	↓ 3.01%

	Q1 FY25	Q/Q Change
Revenue	$123.6M	↓ 4.37%
Net Income	$-154.0K	↓ 102.08%
Net Profit Margin	-0.12%	↓ 5.85%

	Q2 FY25	Q/Q Change
Revenue	$130.2M	↑ 5.32%
Net Income	$10.6M	↓ 7006.49%
Net Profit Margin	8.17%	↑ 8.29%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$150.0M	↓ 17.02%

	FY20	Y/Y Change
Profit	$91.6M	↓ 38.92%

	FY21	Y/Y Change
Profit	$83.8M	↓ 8.5%

	FY22	Y/Y Change
Profit	$78.9M	↓ 5.87%

	FY23	Y/Y Change
Profit	$94.0M	↑ 19.17%

	FY24	Y/Y Change
Profit	$88.4M	↓ 6.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$21.2M	↓ 7.07%

	Q2 FY24	Q/Q Change
Profit	$23.9M	↑ 12.6%

	Q3 FY24	Q/Q Change
Profit	$23.9M	↑ 0.16%

	Q4 FY24	Q/Q Change
Profit	$19.4M	↓ 18.99%

	Q1 FY25	Q/Q Change
Profit	$20.4M	↑ 5.29%

	Q2 FY25	Q/Q Change
Profit	$22.8M	↑ 11.71%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$89.5M	↓ 19.94%
Investing Cash Flow	$-5.7M	↓ 91.96%
Financing Cash Flow	$-85.9M	↑ 102.19%

	FY20	Y/Y Change
Operating Cash Flow	$57.9M	↓ 35.36%
Investing Cash Flow	$7.9M	↓ 238.29%
Financing Cash Flow	$-63.0M	↓ 26.63%

	FY21	Y/Y Change
Operating Cash Flow	$36.6M	↓ 36.79%
Investing Cash Flow	$-10.2M	↓ 230.21%
Financing Cash Flow	$-22.5M	↓ 64.35%

	FY22	Y/Y Change
Operating Cash Flow	$25.0M	↓ 31.78%
Investing Cash Flow	$-3.9M	↓ 62.28%
Financing Cash Flow	$-23.4M	↑ 4.08%

	FY23	Y/Y Change
Operating Cash Flow	$24.8M	↓ 0.67%
Investing Cash Flow	$-6.7M	↑ 72.51%
Financing Cash Flow	$-18.4M	↓ 21.09%

	FY24	Y/Y Change
Operating Cash Flow	$56.4M	↑ 127.47%
Investing Cash Flow	$-6.4M	↓ 3.88%
Financing Cash Flow	$-46.0M	↑ 149.16%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$5.5M	↓ 71.54%
Investing Cash Flow	$-1.7M	↓ 32.26%
Financing Cash Flow	$-4.1M	↓ 77.92%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$17.1M	↑ 210.05%
Investing Cash Flow	$-677.6K	↓ 59.1%
Financing Cash Flow	$-13.7M	↑ 235.22%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$13.1M	↓ 23.61%
Investing Cash Flow	$-491.0K	↓ 27.54%
Financing Cash Flow	$-8.8M	↓ 35.46%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$20.6M	↑ 57.4%
Investing Cash Flow	$-3.6M	↑ 624.85%
Financing Cash Flow	$-19.4M	↑ 119.47%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$6.7M	↓ 67.69%
Investing Cash Flow	$772.0K	↓ 121.69%
Financing Cash Flow	$-4.5M	↓ 76.86%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$13.9M	↑ 109.05%
Investing Cash Flow	$-1.6M	↓ 312.95%
Financing Cash Flow	$-3.2M	↓ 28.65%

Core Laboratories Technicals Summary

Sell

Neutral

Buy

Core Laboratories is currently in a neutral trading position according to technical analysis indicators.

Core Laboratories Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Core Laboratories Inc	-3.8%	-23.86%	-43.28%	-31.7%	-46.77%
Technipfmc Plc	-2.53%	24.18%	35.91%	338.9%	374.81%
Schlumberger Limited	0.98%	-13.63%	-18.56%	-6.98%	89.27%
Baker Hughes Company	-2.12%	0.43%	27.0%	78.76%	213.59%
Halliburton Company	-3.38%	-15.43%	-28.94%	-26.52%	37.82%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Core Laboratories Inc	17.94	17.94	1.67	0.73	0.12	0.05	0.0	5.62
Technipfmc Plc	17.41	17.41	2.73	2.19	0.3	0.08	0.01	7.91
Schlumberger Limited	12.1	12.1	4.89	2.9	0.19	0.08	0.03	15.03
Baker Hughes Company	14.53	14.53	6.13	2.41	0.18	0.06	0.02	17.96
Halliburton Company	10.27	10.27	11.42	2.13	0.18	0.08	0.03	12.32

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Core Laboratories Inc	Hold	$521.5M	-46.77%	17.94	5.73%
Technipfmc Plc	Buy	$15.0B	374.81%	17.41	9.86%
Schlumberger Limited	Buy	$52.7B	89.27%	12.1	11.53%
Baker Hughes Company	Buy	$43.8B	213.59%	14.53	11.04%
Halliburton Company	Buy	$18.7B	37.82%	10.27	8.38%

About Core Laboratories Inc

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Organization	Core Laboratories
Employees	3300
CEO	Mr. Lawrence V. Bruno
Industry	Industrial Services

Key Management of Core Laboratories Inc

Name	Title
Mr. Lawrence V. Bruno	Chairman of the Board, CEO, President & COO
Mr. Christopher Scott Hill	Senior VP & CFO
Ms. Gwendolyn Y. Gresham M.B.A.	Senior Vice President of Corporate Development & Investor Relations
Mr. Mark Damian Tattoli	Senior VP, Secretary & General Counsel
Mr. Sow Hang Teo	VP, Treasurer & Chief Accounting Officer
Leslie D. Linklater	Vice President People, Organization, & Culture
Mr. Jacobus Schouten	Managing Director
J. Donald Dumas Jr.	Senior VP of Production Enhancement & Business Development
Billy Anthony	President of Owen Oil Tools

Important FAQs about investing in CLB Stock from India :

What is Core Laboratories share price today?

Core Laboratories share price today is $11.33 as on August 29, 2025 at 1:29 am IST at the close of the market. Core Laboratories share today touched a day high of $11.33 and a low of $11.00.

What is the 52 week high and 52 week low for Core Laboratories share?

Core Laboratories share touched a 52 week high of $21.83 and a 52 week low of $9.72. Core Laboratories stock price today i.e. August 29, 2025 at 1:29 am IST is closed at $11.33, lower by 48.1% versus the 52 week high.

How to invest in Core Laboratories Stock (CLB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Core Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Core Laboratories Shares that will get you 0.1324 shares as per Core Laboratories share price of $11.33 per share as on August 29, 2025 at 1:29 am IST.

What is the minimum amount required to buy Core Laboratories Stock (CLB) from India?

Indian investors can start investing in Core Laboratories (CLB) shares with as little as ₹87.6463 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.46 in Core Laboratories stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Core Laboratories share’s latest price of $11.33 as on August 29, 2025 at 1:29 am IST, you will get 0.8826 shares of Core Laboratories. Learn more about fractional shares .

What are the returns that Core Laboratories has given to Indian investors in the last 5 years?

Core Laboratories stock has given -46.77% share price returns and 18.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?